Cystic Fibrosis Therapeutics Market Expands with Innovations in Gene Therapy & CFTR Modulator Treatments
[Hyderabad, March 10th, 2025] —The Cystic Fibrosis Therapeutics Market is experiencing robust growth, driven by advances in gene therapy, developments in CFTR modulators, and the rising adoption of personalized CF treatments. Valued at USD 11.21 billion in 2023, the market is projected to grow at a CAGR of 14.75% from 2024 to 2031, reaching USD 33.69 billion by 2031. Request Sample @...
0 Commentaires 0 Parts 24 Vue 0 Aperçu
Commandité